BOT — Botanix Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$32.81m
- AU$8.12m
- AU$33.80m
Brief: Botanix Pharmaceuticals Secures Commitments For A$70 Mln
Brief: Botanix Pharmaceuticals Says FDA Approved Co's New Drug Application
Brief: Botanix Pharmaceuticals Seeks Trading Halt
Brief: Botanix Pharmaceuticals Submitted Last Label Materials To US FDA
Brief: Botanix Pharmaceuticals Appoints Graeme Morissey CFO
Brief: Botanix Pharmaceuticals Posts Loss For Half-Year Attributable A$5.5 Million
Brief: Botanix Pharmaceuticals Says NDA Resubmission Accepted
Brief: Botanix Pharmaceuticals Says Completed Resubmission Of New Drug Application For Sofdra
Brief: Botanix Pharmaceuticals Says FDA Confirms Approach To Sofdra™ NDA Resubmission And Materials Required
Brief: Botanix Pharmaceuticals Successfully Completes A$13.5M Institutional Placement
Australia's Botanix Pharmaceuticals stumbles on discounted placement
Brief: Botanix Pharmaceuticals Secures Commitments For A$13.5 Million Via Institutional Placement
Brief: Botanix Pharmaceuticals Seeks Trading Halt
Brief: Botanix Pharmaceuticals Planning For Approval From FDA For Sofdra In Mid-2024
Australia's Botanix Pharmaceuticals gains on agreement with UpScriptHealth
Australia's Botanix Pharmaceuticals tumbles on anticipated delay in FDA nod for gel
Brief: Botanix Pharmaceuticals Seeks Trading Halt
Brief: Botanix Pharmaceuticals Appoints Howie Mckibbon As CEO
Brief: Fresh Tracks Announces $8.25 Mln Buyout Of Its Right To Receive Future Sofpironium Bromide Payments From Botanix